Search Results - "SEBOKOVA, Elena"

Refine Results
  1. 1
  2. 2

    Dipeptidyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type 2 diabetes by Sebokova, Elena, Christ, Andreas D, Boehringer, Markus, Mizrahi, Jacques

    Published in Current topics in medicinal chemistry (01-03-2007)
    “…Type 2 diabetes is a chronic metabolic disease characterized by the presence of both fasting and postprandial hyperglycemia which is a result of pancreas…”
    Get more information
    Journal Article
  3. 3

    Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats by Smith, Susan Y., Samadfam, Rana, Chouinard, Luc, Awori, Malaika, Bénardeau, Agnes, Bauss, Frieder, Guldberg, Robert E., Sebokova, Elena, Wright, Matthew B.

    Published in Journal of bone and mineral metabolism (01-11-2015)
    “…Pioglitazone, the peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist is an effective therapy for type 2 diabetes, but has been associated with…”
    Get full text
    Journal Article
  4. 4

    Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome by Hansen, Barbara C, Tigno, Xenia T, Bénardeau, Agnes, Meyer, Markus, Sebokova, Elena, Mizrahi, Jacques

    Published in Cardiovascular diabetology (20-01-2011)
    “…Glycemic control and management of dyslipidemia to reduce cardiovascular risk are major therapeutic goals in individuals with type 2 diabetes mellitus (T2DM)…”
    Get full text
    Journal Article
  5. 5

    Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats by Wein, Silvia, Wolffram, Siegfried, Schrezenmeir, Jürgen, Gašperiková, Daniela, Klimeš, Iwar, Šeböková, Elena

    Published in Diabetes/metabolism research and reviews (01-02-2009)
    “…Background High dietary intake of saturated fat impairs insulin sensitivity and lipid metabolism. The influence of fatty acid chain length, however, is not yet…”
    Get full text
    Journal Article
  6. 6

    Increased thyroid volume and frequency of thyroid disorders signs in schoolchildren from nitrate polluted area by Tajtáková, Mária, Semanová, Zuzana, Tomková, Zlatica, Szökeová, Edita, Majoroš, Jozef, Rádiková, Žofia, Šeböková, Elena, Klimeš, Iwar, Langer, Pavel

    Published in Chemosphere (Oxford) (2006)
    “…Thyroid volume (ThV) and echogenicity by ultrasound were estimated in 324 schoolchildren (aged between 10 and 13-years) from high nitrate area (HNA) located in…”
    Get full text
    Journal Article
  7. 7

    Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance by Madsen, Lise, Guerre-Millo, Michéle, Flindt, Esben N, Berge, Kjetil, Tronstad, Karl Johan, Bergene, Elin, Sebokova, Elena, Rustan, Arild C, Jensen, Jørgen, Mandrup, Susanne, Kristiansen, Karsten, Klimes, Iwar, Staels, Bart, Berge, Rolf K

    Published in Journal of lipid research (01-05-2002)
    “…Tetradecylthioacetic acid (TTA) is a non-beta-oxidizable fatty acid analog, which potently regulates lipid homeostasis. Here we evaluate the ability of TTA to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo by Saha, A.K, Laybutt, D.R, Dean, D, Vavvas, D, Sebokova, E, Ellis, B, Klimes, I, Kraegen, E.W, Shafrir, E, Ruderman, N.B

    Published in The American journal of physiology (01-06-1999)
    “…In liver, insulin and glucose acutely increase the concentration of malonyl-CoA by dephosphorylating and activating acetyl-CoA carboxylase (ACC). In contrast,…”
    Get full text
    Journal Article
  10. 10

    Possible effects of environmental nitrates and toxic organochlorines on human thyroid in highly polluted areas in Slovakia by Rádiková, Zofia, Tajtáková, Mária, Kocan, Anton, Trnovec, Tomás, Seböková, Elena, Klimes, Iwar, Langer, Pavel

    Published in Thyroid (New York, N.Y.) (01-03-2008)
    “…Heavy environmental pollution resulting from uncontrolled industrial and agricultural activities has occurred in several areas of Slovakia. So far, field…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Taspoglutide, an Analog of Human Glucagon-Like Peptide-1 with Enhanced Stability and in Vivo Potency by Sebokova, Elena, Christ, Andreas D, Wang, Haiyan, Sewing, Sabine, Dong, Jesse Z, Taylor, John, Cawthorne, Michael A, Culler, Michael D

    Published in Endocrinology (Philadelphia) (01-06-2010)
    “…Taspoglutide is a novel analog of human glucagon-like peptide-1 [hGLP-1(7-36)NH2] in clinical development for the treatment of type 2 diabetes. Taspoglutide…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Combination treatment with pioglitazone and fenofibrate attenuates pioglitazone-mediated acceleration of bone loss in ovariectomized rats by Samadfam, Rana, Awori, Malaika, Bénardeau, Agnes, Bauss, Frieder, Sebokova, Elena, Wright, Matthew, Smith, Susan Y

    Published in Journal of endocrinology (01-02-2012)
    “…Peroxisome proliferator-activated receptor (PPAR) γ agonists, such as pioglitazone (Pio), improve glycemia and lipid profile but are associated with bone loss…”
    Get full text
    Journal Article
  20. 20